0 projects

NAERINGSPH-Nærings-phd

Selection and identification of antibodies that bind to a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma

The partners are currently working on a new method for selecting the slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. When a slow-cycling cell population has been selected it will be used in panning against Affitechs naïve antibody l ibrary. This library is the basis for the...

Awarded: NOK 1.7 mill.

Project Period: 2010-2014

Location: Oslo

BIA-Brukerstyrt innovasjonsarena

Genetic and Process Optimizations for Effective Screening and Functional Production of Novel Therapeutic Antibody Fragments

The application range of antibodies in medicine and biotechnology is broad and there is a huge progress in the design and selection of new variants with novel properties. Affitech is a relative young biotech company founded in 1997, and is still establish ed in the international forefront of disc...

Awarded: NOK 4.0 mill.

Project Period: 2009-2011

Location: Oslo

FUGE-Funksjonell genomforskn.i Norg

Immunoproteomics: Development of new cancer diagnostics and therapeutics by using the immunogenic part of the cancer proteome

Antibodies are long known to be valuable tools for cancer diagnostic. Within the last few yeard, the first antibodies for cancer therapy use have been introduced to the market with excellent results, and possibilities for developing cancer vaccines are w ithin reach. However, identifying tumour...

Awarded: NOK 5.4 mill.

Project Period: 2003-2008

Location: Oslo